The Pharmacy Times® HIV Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of HIV, a virus that attacks the body's immune system and, if left untreated, can lead to AIDS.
April 26th 2024
The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacist Credit)
2.0 Credits / HIV/AIDS
View More
Navigating Approved Pre-exposure Prophylaxis (PrEP) Options for HIV Prevention: The Expanding Role of Pharmacists as Patient Educators and Advocates (Pharmacy Technician Credi...
2.0 Credits / HIV/AIDS
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Treatment Decision-Making for Complex Patients With HIV: Drug Resistance, Adverse Effects, Comorbidities and Polypharmacy, and Overcoming Barriers to Equitable Care
1.5 Credits / HIV/AIDS
View More
Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence
1.5 Credits / HIV/AIDS, Infectious Disease
View More
Topical Agents to Prevent HIV Transmission
February 1st 2014The race is on to develop a topical preventive agent for reducing the transmission of HIV. Researchers at the University of Texas report in vitro efficacy of a vaginal cream containing silver nanoparticles. Other researchers are already reporting favorable results in human studies of an antiretroviral-containing gel.
Read More
Antiretroviral Therapy Adherence Suboptimal, But Not in Patients on Single-Tablet Therapies
January 30th 2014Most patients receiving antiretroviral therapy do not meet the minimum threshold for medication adherence, but patients on single-tablet medication regimens tended to meet that threshold.
Read More
HIV/HCV Coinfection, Regimen Complexity, and Response to Treatment
August 26th 2013Investigators in Spain have identified a relationship between higher-complexity medication regimens and a lower likelihood of sustained viral response (SVR) after treatment for hepatitis C virus (HCV) infection.
Read More
Study: Community Pharmacy HIV Services Provide Support, but Could Improve
August 21st 2013In a new study published in the Journal of Managed Care Pharmacy, investigators interviewed patients and pharmacists about the costs and benefits of obtaining antiretroviral therapies from a community pharmacy.
Read More
Drug Approvals to Treat Neglected Diseases Have Nearly Doubled
July 12th 2013A new study released by the Tufts Center for the Study of Drug Development reports that annual drug approvals for neglected diseases have nearly doubled since 2000, and patient access to these therapies has improved markedly.
Read More